V, Russia's Covid-19 Vaccine Is Showing Positive Results!

A news conference at the Science and Practice Center for Interventional Cardioangiology in Moscow Russia 15 July 2020

A news conference at the Science and Practice Center for Interventional Cardioangiology in Moscow Russia 15 July 2020

In a statement released late on Sunday, the Federal Government said that contingent on the outcome of ongoing trials, vaccines would be made available "progressively" throughout 2021, following a $1.7 billion supply and production agreement with pharmaceutical companies AstraZeneca and CSL/Seqirus.

"This is to inform you that the subject proposal was examined in consultation with SEC (COVID-19) experts held through virtual meeting on 03-09-2020, wherein the committee recommended for the conduct of Phase II part of clinical trials with 380 participants subject to the condition that time for screening the participants should be revised to 4 days", reads the letter dated September 3.

The vaccine was registered in Russian Federation in August, before it had gone through large-scale trials.

"The data on the Russian vaccine studies reported in The Lancet are encouraging", said Brendan Wren, professor of microbial pathogenesis, London School of Hygiene and Tropical Medicine.

The World Health Organization (WHO) has moved to secure an initial 230 million doses of Covid-19 vaccines for Africa, while also advocating that any vaccine in development should also be tested on the continent. "The immunogenicity bodes well...."

The British publication, one of the oldest and best-respected medical journals in the world, confirmed that the Sputnik V vaccine had successfully produced antibodies in all 76 participants in early-stage trials.

The Gamaleya vaccine is given in two doses, and each dose uses a different adenovirus vector.

Facebook limits forwarding on Messenger to fight misinformation
Speaking of elections, Facebook has also announced that it won't accept new political ads in the week preceding the USA elections. It's now limited to certain countries, though the feature will be available to all users globally starting September 24.

Adar Poonawalla, Chief Executive Officer of the Pune-based firm, had said the coronavirus vaccine might be ready by the end of this year.

The Russia Direct Investment Fund, a sovereign wealth fund created by the Russian government for joint partnerships, had last month signalled its intention to conduct clinical trials and seek mass production of the vaccine in India.

He said Russian Federation appreciated that Indian researchers asked questions about how the vaccine works.

If the results are conclusive, Sanofi and GSK hope to get the vaccine approved in the first half of next year.

He said Nigeria contacted Russian Federation for right of access to its vaccine immediately the European giant announced its breakthrough.

But with the results now published for the first time in an global peer-reviewed journal, and with a 40,000-strong later-stage trial launched last week, a senior Russian official said Moscow had answered its critics overseas.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.